- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
InSite Vision Inc+ Add to Watchlist
INSV:US0.1905 USD 0.0145 7.07%
As of 20:10:09 ET on 02/27/2015.
Company Profile for InSite Vision Inc (INSV)
InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.
InSite Vision Inc
Key Executives for InSite Vision Inc (INSV)
|Timothy M RuaneChief Executive Officer||Louis C DrapeauVP/CFO|
|Kamran HosseiniVP:Clinical & Regulatory||Lyle M BowmanVP:Development/Secretary|
|Surendra PatelVP:Operations & Quality|